Clarithromycin in the treatment of community-acquired lower respiratory tract infections
- 30 September 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Hospital Infection
- Vol. 19, 21-27
- https://doi.org/10.1016/0195-6701(91)90214-s
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 1991
- In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1988
- Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibioticEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycinAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987